Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

被引：0

作者：

Ryoko Sakai

Soo-Kyung Cho

Toshihiro Nanki

Kaori Watanabe

Hayato Yamazaki

Michi Tanaka

Ryuji Koike

Yoshiya Tanaka

Kazuyoshi Saito

Shintaro Hirata

Koichi Amano

Hayato Nagasawa

Takayuki Sumida

Taichi Hayashi

Takahiko Sugihara

Hiroaki Dobashi

Shinsuke Yasuda

Tetsuji Sawada

Kazuhiko Ezawa

Atsuhisa Ueda

Takao Fujii

Kiyoshi Migita

Nobuyuki Miyasaka

Masayoshi Harigai

机构：

[1] Graduate School of Medical and Dental Sciences,Department of Pharmacovigilance

[2] Tokyo Medical and Dental University,Department of Rheumatology

[3] Graduate School of Medical and Dental Sciences,Department of Rheumatology

[4] Tokyo Medical and Dental University,Clinical Research Center

[5] Hanyang University Hospital for Rheumatic Diseases,Global Center of Excellence (GCOE) Program

[6] Tokyo Medical and Dental University Hospital,The First Department of Internal medicine

[7] International Research Center for Molecular Science in Tooth and Bone Diseases,Department of Rheumatology/Clinical Immunology

[8] University of Occupational and Environmental Health,Division of Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences

[9] Saitama Medical Center,Department of Rheumatology

[10] Saitama Medical University,Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine

[11] University of Tsukuba,Division of Rheumatology, Endocrinology and Nephrology

[12] Tokyo Metropolitan Geriatric Hospital,Department of Rheumatology

[13] Faculty of Medicine,Department of Internal Medicine

[14] Kagawa University,Department of Internal Medicine and Clinical Immunology

[15] Hokkaido University Graduate School of Medicine,Department of the Control for Rheumatic Diseases, Graduate School of Medicine

[16] Tokyo Medical University,Department of Rheumatology

[17] Kurashiki Kousai Hospital,undefined

[18] Yokohama City University Graduate School of Medicine,undefined

[19] Kyoto University,undefined

[20] National Hospital Organization Nagasaki Medical Center,undefined

来源：

Arthritis Research & Therapy | / 17卷

关键词：

Rheumatoid Arthritis Patient; Herpes Zoster; Tocilizumab; Abatacept; Tumor Necrosis Factor Inhibitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
Sakai, Ryoko
Cho, Soo-Kyung
Nanki, Toshihiro
Watanabe, Kaori
Yamazaki, Hayato
Tanaka, Michi
Koike, Ryuji
Tanaka, Yoshiya
Saito, Kazuyoshi
Hirata, Shintaro
Amano, Koichi
Nagasawa, Hayato
Sumida, Takayuki
Hayashi, Taichi
Sugihara, Takahiko
Dobashi, Hiroaki
Yasuda, Shinsuke
Sawada, Tetsuji
Ezawa, Kazuhiko
Ueda, Atsuhisa
Fujii, Takao
Migita, Kiyoshi
Miyasaka, Nobuyuki
Harigai, Masayoshi
[J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
[2] Registry of Japanese rheumatoid arthritis patients on biologics for long-term safety
Harigai, M
Koike, R
Ogawa, J
Takeuchi, T
Eguchi, K
Miyasaka, N
[J]. DRUG SAFETY, 2005, 28 (10) : 948 - 949
[3] Head-to-Head Comparison of the Retention Rate of First Biologics in Elderly Patients with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
Hayashi, Masatoshi
Kanamono, Toshihisa
Matsubara, Hiroyuki
Kojima, Toshihisa
Funahashi, Koji
Takahashi, Nobunori
Ishiguro, Naoki
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
[4] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS (RA) PATIENTS (PTS)
van Vollenhoven, Ronald
Scali, Juan
Curtis, Jeffrey R.
Krasnow, Joel
Vernon, Emma
Alten, Rieke
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1087 - 1087
[5] The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
Ryoko Sakai
Soo-Kyung Cho
Toshihiro Nanki
Ryuji Koike
Kaori Watanabe
Hayato Yamazaki
Hayato Nagasawa
Koichi Amano
Yoshiya Tanaka
Takayuki Sumida
Atsushi Ihata
Shinsuke Yasuda
Atsuo Nakajima
Takahiko Sugihara
Naoto Tamura
Takao Fujii
Hiroaki Dobashi
Yasushi Miura
Nobuyuki Miyasaka
Masayoshi Harigai
[J]. Rheumatology International, 2014, 34 : 1729 - 1736
[6] The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database
Sakai, Ryoko
Cho, Soo-Kyung
Nanki, Toshihiro
Koike, Ryuji
Watanabe, Kaori
Yamazaki, Hayato
Nagasawa, Hayato
Amano, Koichi
Tanaka, Yoshiya
Sumida, Takayuki
Ihata, Atsushi
Yasuda, Shinsuke
Nakajima, Atsuo
Sugihara, Takahiko
Tamura, Naoto
Fujii, Takao
Dobashi, Hiroaki
Miura, Yasushi
Miyasaka, Nobuyuki
Harigai, Masayoshi
[J]. RHEUMATOLOGY INTERNATIONAL, 2014, 34 (12) : 1729 - 1736
[7] Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
Kim, Seoyoung C.
Solomon, Daniel H.
Rogers, James R.
Gale, Sara
Klearman, Micki
Sarsour, Khaled
Schneeweiss, Sebastian
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[8] Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety
Komano, Yukiko
Tanaka, Michi
Nanki, Toshihiro
Koike, Ryuji
Sakai, Ryoko
Kameda, Hideto
Nakajima, Atsuo
Saito, Kazuyoshi
Takeno, Mitsuhiro
Atsumi, Tatsuya
Tohma, Shigeto
Ito, Satoshi
Tamura, Naoto
Fujii, Takao
Sawada, Tetsuji
Ida, Hiroaki
Hashiramoto, Akira
Koike, Takao
Ishigatsubo, Yoshiaki
Eguchi, Katsumi
Tanaka, Yoshiya
Takeuchi, Tsutomu
Miyasaka, Nobuyuki
Harigai, Masayoshi
[J]. JOURNAL OF RHEUMATOLOGY, 2011, 38 (07) : 1258 - 1264
[9] LONG-TERM SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND A MEAN TREATMENT DURATION OF 3.7 YEARS
Smith, M.
Taylor, A.
Youssef, P.
Hall, S.
Nash, P.
Sebba, A.
Rubbert-Roth, A.
Scali, J.
Alten, R.
Kremer, J.
Pitts, L.
Van Vollenhoven, R.
Genovese, M.
[J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 33 - 33
[10] Long-Term Retention Rate of First Biologics in Patients of Age over 75 Years with Rheumatoid Arthritis in Japanese Clinical Practice: Results from the Multicenter Biologic Registry
Hayashi, Masatoshi
Kanamono, Toshihisa
Matsubara, Hiroyuki
Kojima, Toshihisa
Funahashi, Koji
Takahashi, Nobunori
Ishiguro, Naoki
[J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67

← 1 2 3 4 5 →